19-3600392-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001060.6(TBXA2R):c.243C>T(p.Thr81=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0943 in 1,613,254 control chromosomes in the GnomAD database, including 7,579 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.10 ( 892 hom., cov: 32)
Exomes 𝑓: 0.094 ( 6687 hom. )
Consequence
TBXA2R
NM_001060.6 synonymous
NM_001060.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.73
Genes affected
TBXA2R (HGNC:11608): (thromboxane A2 receptor) This gene encodes a member of the G protein-coupled receptor family. The protein interacts with thromboxane A2 to induce platelet aggregation and regulate hemostasis. A mutation in this gene results in a bleeding disorder. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 19-3600392-G-A is Benign according to our data. Variant chr19-3600392-G-A is described in ClinVar as [Benign]. Clinvar id is 263266.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.73 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.132 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TBXA2R | NM_001060.6 | c.243C>T | p.Thr81= | synonymous_variant | 2/3 | ENST00000375190.10 | |
TBXA2R | NM_201636.3 | c.243C>T | p.Thr81= | synonymous_variant | 2/4 | ||
TBXA2R | XM_011528214.3 | c.243C>T | p.Thr81= | synonymous_variant | 3/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TBXA2R | ENST00000375190.10 | c.243C>T | p.Thr81= | synonymous_variant | 2/3 | 1 | NM_001060.6 | P1 | |
TBXA2R | ENST00000589966.1 | c.243C>T | p.Thr81= | synonymous_variant | 1/2 | 1 | |||
TBXA2R | ENST00000411851.3 | c.243C>T | p.Thr81= | synonymous_variant | 2/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.101 AC: 15313AN: 152070Hom.: 891 Cov.: 32
GnomAD3 genomes
AF:
AC:
15313
AN:
152070
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0814 AC: 20014AN: 245816Hom.: 929 AF XY: 0.0822 AC XY: 11017AN XY: 134074
GnomAD3 exomes
AF:
AC:
20014
AN:
245816
Hom.:
AF XY:
AC XY:
11017
AN XY:
134074
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0936 AC: 136795AN: 1461066Hom.: 6687 Cov.: 33 AF XY: 0.0933 AC XY: 67785AN XY: 726864
GnomAD4 exome
AF:
AC:
136795
AN:
1461066
Hom.:
Cov.:
33
AF XY:
AC XY:
67785
AN XY:
726864
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.101 AC: 15317AN: 152188Hom.: 892 Cov.: 32 AF XY: 0.0981 AC XY: 7303AN XY: 74410
GnomAD4 genome
AF:
AC:
15317
AN:
152188
Hom.:
Cov.:
32
AF XY:
AC XY:
7303
AN XY:
74410
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
157
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at